Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership(A) |
2021-03-30 5:44 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR ONE CAPITAL MANAGEMENT LLC 10% Owner |
0 | $0 | 5,376,476 (Direct) |
View |
2021-03-25 Option Award |
2021-03-29 6:31 pm |
N/A 2031-03-24 |
Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
2021-03-25 Option Award |
2021-03-29 5:56 pm |
N/A 2031-03-24 |
Design Therapeutics Inc. | DSGN | William Arsani Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-03-25 Option Award |
2021-03-29 5:55 pm |
N/A 2031-03-24 |
Design Therapeutics Inc. | DSGN | Schmid John P. Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-03-25 Option Award |
2021-03-29 5:54 pm |
N/A 2031-03-24 |
Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-03-25 Option Award |
2021-03-29 5:52 pm |
N/A 2031-03-24 |
Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
Ownership |
2021-03-25 9:17 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP 10% Owner |
0 | $0 | 5,376,476 (Direct) |
View |
Ownership |
2021-03-25 9:15 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Xu Stella Quan Venture Fund II L.P. Director 10% Owner |
0 | $0 | 4,720,830 (Indirect) |
View |
Ownership |
2021-03-25 9:15 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | William Arsani Director |
0 | $0 | 2,032,501 (Indirect) |
View |
Ownership |
2021-03-25 9:14 pm |
N/A 2030-12-06 |
Design Therapeutics Inc. | DSGN | Thacker Justin Vice President, Finance |
0 | $0 | 92,024 (Direct) |
View |
Ownership |
2021-03-25 9:12 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Star Irrevocable Trust #1 dated April 22 2019 10% Owner |
0 | $0 | 3,834,355 (Direct) |
View |
Ownership |
2021-03-25 9:10 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Siffert Joao MD President and CEO |
0 | $0 | 766,870 (Direct) |
View |
Ownership |
2021-03-25 9:09 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson |
0 | $0 | 104,923 (Indirect) |
View |
Ownership |
2021-03-25 9:08 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Schmid John P. Director |
0 | $0 | 30,674 (Direct) |
View |
Ownership |
2021-03-25 9:07 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Light Irrevocable Trust #1 dated April 22 2019 10% Owner |
0 | $0 | 3,834,355 (Direct) |
View |
Ownership |
2021-03-25 9:06 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director |
0 | $0 | 92,024 (Direct) |
View |
Ownership |
2021-03-25 9:02 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner |
0 | $0 | 5,376,476 (Indirect) |
View |
Ownership |
2021-03-25 8:55 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Jeffries Sean Chief Operating Officer |
0 | $0 | 807,233 (Direct) |
View |
Ownership |
2021-03-25 8:51 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Ansari Aseem Z. 10% Owner |
0 | $0 | 7,668,711 (Direct) |
View |
Ownership |
2021-03-25 5:11 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP 10% Owner |
0 | $0 | 4,364,844 (Indirect) |
View |